Literature DB >> 22074555

Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.

Akash K Jain1, Santanu Bhattacharya.   

Abstract

The enzyme telomerase synthesizes the G-rich DNA strands of the telomere and its activity is often associated with cancer. The telomerase may be therefore responsible for the ability of a cancer cell to escape apoptosis. The G-rich DNA sequences often adopt tetra-stranded structure, known as the G-quadruplex DNA (G4-DNA). The stabilization of the telomeric DNA into the G4-DNA structures by small molecules has been the focus of many researchers for the design and development of new anticancer agents. The compounds which stabilize the G-quadruplex in the telomere inhibit the telomerase activity. Besides telomeres, the G4-DNA forming sequences are present in the genomic regions of biological significance including the transcriptional regulatory and promoter regions of several oncogenes. Inducing a G-quadruplex structure within the G-rich promoter sequences is a potential way of achieving selective gene regulation. Several G-quadruplex stabilizing ligands are known. Minor groove binding ligands (MGBLs) interact with the double-helical DNA through the minor grooves sequence-specifically and interfere with several DNA associated processes. These MGBLs when suitably modified switch their preference sometimes from the duplex DNA to G4-DNA and stabilize the G4-DNA as well. Herein, we focus on the recent advances in understanding the G-quadruplex structures, particularly made by the human telomeric ends, and review the results of various investigations of the interaction of designed organic ligands with the G-quadruplex DNA while highlighting the importance of MGBL-G-quadruplex interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22074555     DOI: 10.1021/bc200268a

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  9 in total

1.  In-silico modeling studies of G-quadruplex with soy isoflavones having anticancerous activity.

Authors:  Jyoti Singh Tomar
Journal:  J Mol Model       Date:  2015-07-12       Impact factor: 1.810

2.  Stabilization of G-Quadruplex-Duplex Hybrid Structures Induced by Minor Groove-Binding Drugs.

Authors:  Lily Scott; Tigran V Chalikian
Journal:  Life (Basel)       Date:  2022-04-18

3.  Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.

Authors:  Debasish Dutta; Manish Debnath; Diana Müller; Rakesh Paul; Tania Das; Irene Bessi; Harald Schwalbe; Jyotirmayee Dash
Journal:  Nucleic Acids Res       Date:  2018-06-20       Impact factor: 16.971

4.  Berberrubine Phosphate: A Selective Fluorescent Probe for Quadruplex DNA.

Authors:  Peter Jonas Wickhorst; Heiko Ihmels
Journal:  Molecules       Date:  2021-04-28       Impact factor: 4.411

5.  Binding of gemini bisbenzimidazole drugs with human telomeric G-quadruplex dimers: effect of the spacer in the design of potent telomerase inhibitors.

Authors:  Ananya Paul; Akash K Jain; Santosh K Misra; Basudeb Maji; K Muniyappa; Santanu Bhattacharya
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

6.  Knockdown of Broad-Complex Gene Expression of Bombyx mori by Oligopyrrole Carboxamides Enhances Silk Production.

Authors:  Asfa Ali; Venugopal Reddy Bovilla; Danti Kumari Mysarla; Prasanthi Siripurapu; Rashmi U Pathak; Bhakti Basu; Anitha Mamillapalli; Santanu Bhattacharya
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

7.  Ethyl-substitutive Thioflavin T as a highly-specific fluorescence probe for detecting G-quadruplex structure.

Authors:  Ai-Jiao Guan; Xiu-Feng Zhang; Xin Sun; Qian Li; Jun-Feng Xiang; Li-Xia Wang; Ling Lan; Feng-Min Yang; Shu-Juan Xu; Xiao-Meng Guo; Ya-Lin Tang
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

8.  Benzimidazole-1,2,3-triazole hybrid molecules: synthesis and study of their interaction with G-quadruplex DNA.

Authors:  Padma S Singu; Ushasri Chilakamarthi; Namita S Mahadik; Bhamidipati Keerti; Narasimhulu Valipenta; Santosh N Mokale; Narayana Nagesh; Ravindra M Kumbhare
Journal:  RSC Med Chem       Date:  2021-02-22

9.  Targeting telomerase with radiolabeled inhibitors.

Authors:  Philip A Waghorn; Mark R Jackson; Veronique Gouverneur; Katherine A Vallis
Journal:  Eur J Med Chem       Date:  2016-09-10       Impact factor: 7.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.